Lam Research Balance Sheet Health
Financial Health criteria checks 6/6
Lam Research has a total shareholder equity of $8.5B and total debt of $5.0B, which brings its debt-to-equity ratio to 58.8%. Its total assets and total liabilities are $19.5B and $11.1B respectively. Lam Research's EBIT is $4.6B making its interest coverage ratio -57.7. It has cash and short-term investments of $6.1B.
Key information
58.8%
Debt to equity ratio
US$4.98b
Debt
| Interest coverage ratio | -57.7x |
| Cash | US$6.07b |
| Equity | US$8.47b |
| Total liabilities | US$11.06b |
| Total assets | US$19.53b |
Recent financial health updates
Lam Research (NASDAQ:LRCX) Seems To Use Debt Quite Sensibly
Oct 12
Here's Why Lam Research (NASDAQ:LRCX) Can Manage Its Debt Responsibly
Jun 06Lam Research (NASDAQ:LRCX) Has A Pretty Healthy Balance Sheet
Jan 28Recent updates
Lam Research: Semiconductor Giant Still On Sale After Earnings Beat
Dec 04Lam Research: Wait For The Dust To Settle (Technical Analysis)
Nov 28Lam Research (NASDAQ:LRCX) Knows How To Allocate Capital Effectively
Nov 14Why Lam Research Is At A Make-Or-Break Level Before Earnings
Oct 22Lam Research (NASDAQ:LRCX) Seems To Use Debt Quite Sensibly
Oct 12Lam Research Following Micron's Footsteps In High Bandwidth Memory And Semiconductor Equipments Demand
Oct 11Lam Research: The Recent Pullback Is A Buying Opportunity
Sep 16Is Lam Research Corporation (NASDAQ:LRCX) Trading At A 36% Discount?
Sep 15Lam Research's (NASDAQ:LRCX) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 03Lam Research: Finding Opportunity Amidst Q4 FY 2024 Post Earnings Dip
Aug 16Lam Research: China Risk May Offset Memory Recovery And AI Boost
Aug 03The Lam Research Corporation (NASDAQ:LRCX) Full-Year Results Are Out And Analysts Have Published New Forecasts
Aug 02Investors Still Waiting For A Pull Back In Lam Research Corporation (NASDAQ:LRCX)
Jul 28Lam Research: It's Still All About Memory- Maintaining Buy
Jul 11Why Lam Research Corporation (NASDAQ:LRCX) Could Be Worth Watching
Jul 03Capitalizing On The Semiconductor Rebound: Lam Research Is A Compelling Buy
Jul 02Lam Research: Headwinds Coming From Chinese And Japanese Competitors
Jun 07Here's Why Lam Research (NASDAQ:LRCX) Can Manage Its Debt Responsibly
Jun 06Lam Research (NASDAQ:LRCX) Is Aiming To Keep Up Its Impressive Returns
May 23Lam Research: More Wafer Fab Equipment Spend For FY2025, Maintaining Buy
May 18Lam Research Corporation Just Beat EPS By 5.7%: Here's What Analysts Think Will Happen Next
Apr 26Lam Research: Benefiting From HBM-Driven DRAM; Initiate With 'Strong Buy'
Apr 18Lam Research: A Favorite In The Semis - Initiating With A Buy
Apr 09Why We're Not Concerned About Lam Research Corporation's (NASDAQ:LRCX) Share Price
Apr 04Lam Research: Stock Price Runup Justified But Upside Now Limited
Feb 24Here's What's Concerning About Lam Research's (NASDAQ:LRCX) Returns On Capital
Feb 22Investors Can Find Comfort In Lam Research's (NASDAQ:LRCX) Earnings Quality
Feb 09Lam Research Corporation (NASDAQ:LRCX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$872
Jan 31Lam Research (NASDAQ:LRCX) Has A Pretty Healthy Balance Sheet
Jan 28Lam Research: Lack Of Clarity On NAND A Significant Headwind In 2024
Jan 25Lam Research: Positioned Strongly (And Expensively) For AI Secular Trends
Jan 17Lam Research Corporation (NASDAQ:LRCX) Shares Could Be 25% Above Their Intrinsic Value Estimate
Jan 02Lam Research Corporation's (NASDAQ:LRCX) Price Is Out Of Tune With Earnings
Dec 21Financial Position Analysis
Short Term Liabilities: LRCX's short term assets ($13.5B) exceed its short term liabilities ($5.3B).
Long Term Liabilities: LRCX's short term assets ($13.5B) exceed its long term liabilities ($5.7B).
Debt to Equity History and Analysis
Debt Level: LRCX has more cash than its total debt.
Reducing Debt: LRCX's debt to equity ratio has reduced from 89.5% to 58.8% over the past 5 years.
Debt Coverage: LRCX's debt is well covered by operating cash flow (105.7%).
Interest Coverage: LRCX earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 04:35 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/29 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Lam Research Corporation is covered by 68 analysts. 30 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| James Kelleher | Argus Research Company |
| Ishan Majumdar | Baptista Research |
| Thomas O'Malley | Barclays |